GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » ROC %

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) ROC % : 3.06% (As of Mar. 2017)


View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Aoxing Pharmaceutical Co's annualized return on capital (ROC %) for the quarter that ended in Mar. 2017 was 3.06%.

As of today (2024-06-11), Aoxing Pharmaceutical Co's WACC % is 0.00%. Aoxing Pharmaceutical Co's ROC % is 0.00% (calculated using TTM income statement data). Aoxing Pharmaceutical Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Aoxing Pharmaceutical Co ROC % Historical Data

The historical data trend for Aoxing Pharmaceutical Co's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aoxing Pharmaceutical Co ROC % Chart

Aoxing Pharmaceutical Co Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Jun16
ROC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.16 -14.28 -6.90 27.95 8.21

Aoxing Pharmaceutical Co Quarterly Data
Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17
ROC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.84 -9.12 4.61 0.14 3.06

Aoxing Pharmaceutical Co ROC % Calculation

Aoxing Pharmaceutical Co's annualized Return on Capital (ROC %) for the fiscal year that ended in Jun. 2016 is calculated as:

ROC % (A: Jun. 2016 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Jun. 2015 ) + Invested Capital (A: Jun. 2016 ))/ count )
=6.228 * ( 1 - 22.25% )/( (62.675 + 55.251)/ 2 )
=4.84227/58.963
=8.21 %

where

Aoxing Pharmaceutical Co's annualized Return on Capital (ROC %) for the quarter that ended in Mar. 2017 is calculated as:

ROC % (Q: Mar. 2017 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2016 ) + Invested Capital (Q: Mar. 2017 ))/ count )
=3.512 * ( 1 - 51.85% )/( (53.675 + 56.844)/ 2 )
=1.691028/55.2595
=3.06 %

where

Note: The Operating Income data used here is four times the quarterly (Mar. 2017) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aoxing Pharmaceutical Co  (OTCPK:AOXG) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, Aoxing Pharmaceutical Co's WACC % is 0.00%. Aoxing Pharmaceutical Co's ROC % is 0.00% (calculated using TTM income statement data). Aoxing Pharmaceutical Co earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


Aoxing Pharmaceutical Co ROC % Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217
Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.
Executives
Wilfred Chow officer: Chief Financial Officer 30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea director C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo director, officer: Secretary 80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines